Literature DB >> 14693959

Clinical decisions regarding HbA1c results in primary care: a report from CaReNet and HPRN.

Bennett L Parnes1, Deborah S Main, L Miriam Dickinson, Linda Niebauer, Sherry Holcomb, John M Westfall, Wilson D Pace.   

Abstract

OBJECTIVE: To describe decisions made by primary care providers on elevated HbA(1c) results and their reasons for not intensifying therapy. RESEARCH DESIGN AND METHODS: In this cross-sectional study, a provider survey was administered in two practice-based research networks when HbA(1c) results were reviewed on all nonpregnant patients >18 years old with type 2 diabetes. Univariate and Mantel-Hantel analyses assessed associations between patient characteristics and clinical decisions.
RESULTS: A total of 483 surveys were completed by at least 88 providers at 19 clinics. Most patients were female (62.5%), mean age was 60 years, and 28.6% were Hispanic. The overall action rate on HbA(1c) results >/=7% (n = 294) was 70.7%. Patients who were black or had Medicare without medication insurance had lower rates of action on HbA(1c) >/=7 and >/=8%, respectively (P < 0.05). The most common reasons providers reported for inaction were "patient improving/doing well," "competing demands," and "hypoglycemic risk."
CONCLUSIONS: Primary care providers generally adhere to national glycemic control guidelines, although there may be disparities in black patients and patients without medication insurance coverage. A variety of reasons were given when control was not intensified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693959     DOI: 10.2337/diacare.27.1.13

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  13 in total

1.  Electronic data collection options for practice-based research networks.

Authors:  Wilson D Pace; Elizabeth W Staton
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

2.  Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2.

Authors:  Vladimir Curvelo Tavares de Sa; Alvaro A Ferraz; Josemberg M Campos; Almino C Ramos; Jose Guido C Araujo; Edmundo M Ferraz
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

3.  Clinical inertia in patients with T2DM requiring insulin in family practice.

Authors:  Stewart B Harris; Jovana Kapor; Cynthia N Lank; Andrew R Willan; Tricia Houston
Journal:  Can Fam Physician       Date:  2010-12       Impact factor: 3.275

4.  Management of type 2 diabetes in the primary care setting: a practice-based research network study.

Authors:  Stephen J Spann; Paul A Nutting; James M Galliher; Kevin A Peterson; Valory N Pavlik; L Miriam Dickinson; Robert J Volk
Journal:  Ann Fam Med       Date:  2006 Jan-Feb       Impact factor: 5.166

5.  Card studies for observational research in practice.

Authors:  John M Westfall; Linda Zittleman; Elizabeth W Staton; Bennett Parnes; Peter C Smith; Linda J Niebauer; Douglas H Fernald; Javan Quintela; Rebecca F Van Vorst; L Miriam Dickinson; Wilson D Pace
Journal:  Ann Fam Med       Date:  2011 Jan-Feb       Impact factor: 5.166

6.  Designing and Implementing an Electronic Health Record-Embedded Card Study in Primary Care: Methods and Considerations.

Authors:  Arwen Bunce; Mary Middendorf; Megan Hoopes; Jenna Donovan; Rachel Gold
Journal:  Ann Fam Med       Date:  2022 Jul-Aug       Impact factor: 5.707

7.  Lack of impact of direct-to-consumer advertising on the physician-patient encounter in primary care: a SNOCAP report.

Authors:  Bennett Parnes; Peter C Smith; Christine Gilroy; Javan Quintela; Caroline B Emsermann; L Miriam Dickinson; John M Westfall
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

8.  Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study.

Authors:  Qiaoyi Zhang; Elizabeth Marrett; Kevin Jameson; Susanne Meiler; Michael J Davies; Larry Radican; Alan J Sinclair
Journal:  BMC Endocr Disord       Date:  2011-10-28       Impact factor: 2.763

9.  Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study.

Authors:  Jaco Voorham; Flora M Haaijer-Ruskamp; Bruce H R Wolffenbuttel; Dick de Zeeuw; Ronald P Stolk; Petra Denig
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

10.  Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study.

Authors:  Elisabeth AB; Petra Denig; Ton van Vliet; Janny H Dekker
Journal:  BMC Fam Pract       Date:  2009-04-21       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.